Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17
US8329431B2 · kind B2 · utility
6Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2011 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Aug 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.